For what the approved labeling actually warns about, the FDA-approved prescribing information is the authority
corroborated by Oostdyk 2024) and downregulates surface GLP-1R within 12 hours at physiological albumin (Hinds 2024), so the sustained signal held against that fade, set by dose, is what carries the effect
PIONEER-6 (Peptide Innovation for Early Diabetes Treatment) demonstrated the similar cardiovascular benefit of oral semaglutide to that of the subcutaneous form seen in SUSTAIN-6 [16]
Tolerance considerations: Reported effects can be dose-sensitive, and adverse reactions such as nausea, flushing, fatigue , and changes in freckles/moles are commonly cited
"Like most drugs, with the exception of vaccines, they typically only work when youre on them, said Giles Yeo, a genetics professor at the University of Cambridge who reviewed the findings